Moreover, the important role of the RAS/MAPK pathway in growth plate development has been documented in achondroplasia and hypochondroplasia, the most common primary skeletal dysplasias in humans, which are caused by gain of function variants of the fibroblast growth factor receptor 3 (FGFR3) (37). The gene discussed is FGFR3; the disease is hypochondroplasia.